UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3816) 3816
science & technology (2810) 2810
life sciences & biomedicine (2716) 2716
stomach neoplasms - enzymology (2181) 2181
biological and medical sciences (2002) 2002
medical sciences (1973) 1973
tumors (1933) 1933
male (1882) 1882
female (1879) 1879
gastroenterology. liver. pancreas. abdomen (1714) 1714
oncology (1713) 1713
stomach. duodenum. small intestine. colon. rectum. anus (1696) 1696
middle aged (1604) 1604
aged (1346) 1346
stomach neoplasms - pathology (1210) 1210
adult (1066) 1066
gastric cancer (794) 794
animals (753) 753
adenocarcinoma - enzymology (677) 677
colorectal neoplasms - enzymology (672) 672
stomach neoplasms - genetics (664) 664
cell line, tumor (659) 659
immunohistochemistry (656) 656
cancer (586) 586
aged, 80 and over (563) 563
stomach cancer (549) 549
colonic neoplasms - enzymology (527) 527
prognosis (493) 493
mice (444) 444
colorectal cancer (428) 428
gene expression regulation, neoplastic (417) 417
gastric mucosa - enzymology (376) 376
adenocarcinoma - pathology (372) 372
gastroenterology & hepatology (372) 372
stomach neoplasms - drug therapy (371) 371
colorectal neoplasms - pathology (350) 350
neoplasm staging (318) 318
apoptosis (314) 314
tumor cells, cultured (311) 311
colorectal neoplasms - genetics (307) 307
abridged index medicus (298) 298
neoplasm invasiveness (295) 295
pharmacology. drug treatments (295) 295
colonic neoplasms - pathology (280) 280
stomach neoplasms - metabolism (280) 280
gene expression (279) 279
pathology (279) 279
risk factors (272) 272
antineoplastic agents (266) 266
research (252) 252
cell biology (241) 241
reverse transcriptase polymerase chain reaction (236) 236
metastasis (225) 225
gene expression regulation, enzymologic (222) 222
rna, messenger - genetics (220) 220
blotting, western (219) 219
proteins (214) 214
apoptosis - drug effects (211) 211
biochemistry & molecular biology (211) 211
genetic aspects (211) 211
surgery (211) 211
transfection (211) 211
intestinal mucosa - enzymology (210) 210
case-control studies (208) 208
mice, nude (208) 208
signal transduction (208) 208
cell proliferation (203) 203
analysis (200) 200
time factors (200) 200
polymerase chain reaction (196) 196
rna, messenger - metabolism (196) 196
lymphatic metastasis (192) 192
adenoma - enzymology (182) 182
research article (175) 175
biomarkers, tumor - analysis (174) 174
biomarkers, tumor - metabolism (173) 173
pharmacology & pharmacy (173) 173
adenocarcinoma - genetics (172) 172
mutation (172) 172
rats (172) 172
carcinoma - enzymology (170) 170
gastric mucosa - pathology (170) 170
phosphorylation (169) 169
chemotherapy (168) 168
enzymes (167) 167
stomach neoplasms - surgery (166) 166
genotype (164) 164
medicine & public health (164) 164
enzyme activation (162) 162
stomach neoplasms - mortality (162) 162
antineoplastic agents - pharmacology (161) 161
neoplasm metastasis (160) 160
up-regulation (156) 156
isoenzymes - metabolism (154) 154
stomach - enzymology (153) 153
colon cancer (152) 152
development and progression (148) 148
disease progression (147) 147
base sequence (143) 143
polymorphism, genetic (141) 141
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3752) 3752
Japanese (166) 166
Russian (134) 134
Chinese (85) 85
German (29) 29
Polish (22) 22
Spanish (15) 15
French (7) 7
Italian (7) 7
Czech (5) 5
Hungarian (4) 4
Romanian (4) 4
Korean (2) 2
Ukrainian (2) 2
Croatian (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Human pathology, ISSN 0046-8177, 2016, Volume 55, pp. 11 - 16
Journal Article
Journal Article
Cancer science, ISSN 1347-9032, 07/2016, Volume 107, Issue 7, pp. 1039 - 1046
topoisomerase I inhibitor | T‐DM | HER2 | bystander killing | Antibody‐drug conjugate | T-DM | Antibody-drug conjugate | Life Sciences & Biomedicine | Oncology | Science & Technology | Receptor, ErbB-2 - genetics | Breast Neoplasms - immunology | Humans | Ado-Trastuzumab Emtansine | Stomach Neoplasms - pathology | Maytansine - pharmacology | Immunoconjugates - immunology | Breast Neoplasms - enzymology | Immunoconjugates - pharmacology | Topoisomerase I Inhibitors - pharmacology | Neoplasms - genetics | Antibodies, Monoclonal, Humanized - pharmacology | Female | Camptothecin - immunology | Receptor, ErbB-2 - immunology | Camptothecin - analogs & derivatives | Stomach Neoplasms - enzymology | Stomach Neoplasms - genetics | Maytansine - analogs & derivatives | Neoplasms - enzymology | Stomach Neoplasms - immunology | Animals | Breast Neoplasms - genetics | Bystander Effect - drug effects | Breast Neoplasms - pathology | Mice, Nude | Neoplasms - immunology | Cell Membrane Permeability - drug effects | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Antibodies, Monoclonal, Humanized - immunology | Neoplasms - pathology | Camptothecin - pharmacology | Maytansine - immunology | Trastuzumab | Viral antibodies | Epidermal growth factor | Imaging systems | Antibodies | Permeability | Drug therapy | Biopharmaceutics | Tumors | Antigens | Hematology | Laboratories | Toxicity | DNA topoisomerase | Polymerization | Clinical trials | Cytotoxicity | Breast cancer | ErbB-2 protein | Stomach cancer | Lymphoma | Hypotheses | Antitumor agents | Xenografts | Antitumor activity | Drug dosages | Payloads | Index Medicus | Original
Journal Article
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 481 - 489
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Multivariate Analysis | Adenocarcinoma - pathology | Capecitabine | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Stomach Neoplasms - pathology | Epirubicin - administration & dosage | Molecular Targeted Therapy | Esophageal Neoplasms - pathology | Early Termination of Clinical Trials | Organoplatinum Compounds - administration & dosage | Receptor, Epidermal Growth Factor - metabolism | Fluorouracil - administration & dosage | Time Factors | Biomarkers, Tumor - metabolism | Esophageal Neoplasms - mortality | Female | Biomarkers, Tumor - antagonists & inhibitors | Odds Ratio | Stomach Neoplasms - enzymology | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Adenocarcinoma - enzymology | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | United Kingdom | Stomach Neoplasms - drug therapy | Chi-Square Distribution | Adenocarcinoma - drug therapy | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Esophageal Neoplasms - enzymology | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Esophageal Neoplasms - drug therapy | Stomach Neoplasms - mortality | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Care and treatment | Anthracyclines | Product development | Cancer | Index Medicus
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 12/2014, Volume 124, Issue 12, pp. 5145 - 5158
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 12/2013, Volume 31, Issue 34, pp. 4297 - 4305
Journal Article